Role of nitric oxide in mast cells: Controversies, current knowledge, and future applications

Immunologic Research

Volumn 33, Issue 3, 2005, Pages 223-239

  Sekar, Yokananth ^a   Tae, Chul Moon ^a   Muñoz, Samira ^a   Befus, A Dean ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Innate immunity; Mast cells; Mediator release; Nitration; Nitric oxide; Nitrosylation

Indexed keywords

CHEMOKINE; CYTOKINE; GROWTH FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEINASE; PROTEOGLYCAN; TRANSCRIPTION FACTOR;

ALLERGIC DISEASE; ASTROCYTE; CELL FUNCTION; CELL INTERACTION; CROSS LINKING; CYTOLOGY; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MACROPHAGE; MAST CELL; MEDIATOR RELEASE; MICROENVIRONMENT; NITRATION; NITROSYLATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; UPREGULATION;

EID: 32244436605     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:33:3:223     Document Type: Review

References (106)

1. Vliagoftis H, Befus AD: Rapidly changing perspectives about mast cells at mucosal surfaces. Immunol Rev 2005;206:190-203.
2. Marshall JS: Mast-cell responses to pathogens. Nat Rev Immunol 2004;4:787-799.
3. Galli SJ, Nakae S, Tsai M: Mast cells in the development of adaptive immune responses. Nat Immunol 2005;6:135-142.
4. Stassen M, Hultner L, Schmitt E: Classical and alternative pathways of mast cell activation. Crit Rev Immunol 2002;22:115-140.
5. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M: Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005;23:749-786.
6. Maurer M, Theoharides T, Granstein RD, et al: What is the physiological function of mast cells? Exp Dermatol 2003;12:886-910.
7. Krishnaswamy G, Ajitawi O, Chi DS: The human mast cell: an overview. Methods Mol Biol 2005;315:13-34.
8. Bruckdorfer R: The basics about nitric oxide. Mol Aspects Med 2005;26:3-31.
9. Bidri M, Feger F, Varadaradjalou S, Ben Hamouda N, Guillosson JJ, Arock M: Mast cells as a source and target for nitric oxide. Int Immunopharmacol 2001;1:1543-1558.
10. Gilchrist M, McCauley SD, Befus AD: Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production. Blood 2004;104:462-469.
11. McCauley SD, Gilchrist M, Befus AD: Nitric oxide: a major determinant of mast cell phenotype and function. Mem Inst Oswaldo Cruz 2005;100 (Suppl 1):11-14.
12. Forsythe P, Gilchrist M, Kulka M, Befus AD: Mast cells and nitric oxide: control of production, mechanisms of response. Int Immunopharmacol 2001;1:1525-1541.
13. Gilchrist M, Savoie M, Nohara O, Wills FL, Wallace JL, Befus AD: Nitric oxide synthase and nitric oxide production in in vivo-derived mast cells. J Leukoc Biol 2002;71:618-624.
14. Swindle EJ, Metcalfe DD, Coleman JW: Rodent and human mast cells produce functionally significant intracellular reactive oxygen species but not nitric oxide. J Biol Chem 2004;279:48751-48759.
15. Coleman JW: Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin Exp Immunol 2002;129:4-10.
16. Frossi B, De Carli M., Pucillo C: The mast cell: an antenna of the microenvironment that directs the immune response. J Leukoc Biol 2004;75:579-585.
17. Wedemeyer J, Tsai M, Galli SJ: Roles of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol 2000;12:624-631.
18. Feger F, Varadaradjalou S, Gao Z, Abraham SN, Arock M: The role of mast cells in host defense and their subversion by bacterial pathogens. Trends Immunol 2002;23:151-158.
19. Marshall JS, Jawdat DM: Mast cells in innate immunity. J Allergy Clin Immunol 2004;114:21-27.
20. Tkaczyk C Gilfillan AM: Fc(epsilon)Ri-dependent signaling pathways in human mast cells. Clin Immunol 2001;99:198-210.
21. Furumoto Y, Gonzalez-Espinosa C, Gomez G, et al: Rethinking the role of Src family protein tyrosine kinases in the allergic response: new insights on the functional coupling of the high affinity IgE receptor. Immunol Res 2004;30:241-253.
22. Okayama Y, Hagaman DD, Metcalfe DD: A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI. J Immunol 2001;166: 4705-4712.
23. Redegeld FA, Nijkamp FP: Immunoglobulin free light chains and mast cells: pivotal role in T-cell-mediated immune reactions? Trends Immunol 2003;24:181-185.
24. McCurdy JD, Lin TJ, Marshall JS: Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol 2001;70:977-984.
25. Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD: Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 2004;114:174-182.
26. Matsushima H, Yamada N, Matsue H, Shimada S: TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol 2004;173:531-541.
27. Supajatura V, Ushio H, Nakao A, et al: Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 2002;109: 1351-1359.
28. Varadaradjalou S, Feger F, Thieblemont N, et al: Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 2003;33:899-906.
29. Supajatura V, Ushio H, Nakao A, Okumura K, Ra C, Ogawa H: Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol 2001;167:2250-2256.
30. Ferry X, Brehin S, Kamel R, Landry Y: G protein-dependent activation of mast cell by peptides and basic secretagogues. Peptides 2002;23:1507-1515.
31. Okayama Y, Kirshenbaum AS, Metcalfe DD: Expression of a functional high-affinity IgG receptor, Fc gamma RI, on human mast cells: up-regulation by IFN-gamma. J Immunol 2000;164:4332-4339.
32. Gordon JR, Galli SJ: Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990;346:274-276.
33. Kobayashi H, Ishizuka T, Okayama Y: Human mast cells and basophils as sources of cytokines. Clin Exp Allergy 2000;30:1205-1212.
34. Ono SJ, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, Toda M: Chemokines: roles in leukocyte development, trafficking, and effector function. J Allergy Clin Immunol 2003;111:1185-1199.
35. Blease K, Lukacs NW, Hogaboam CM, Kunkel SL: Chemokines and their role in airway hyper-reactivity. Respir Res 2000;1:54-61.
36. Talkington J, Nickell SP: Role of Fc gamma receptors in triggering host cell activation and cytokine release by Borrelia burgdorferi. Infect Immun 2001;69:413-419.
37. Prodeus AP, Zhou X, Maurer M, Galli SJ, Carroll MC: Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 1997;390: 172-175.
38. Malaviya R, Ross EA, MacGregor JI, et al: Mast cell phagocytosis of FimH-expressing enterobacteria. J Immunol 1994;152:1907-1914.
39. Arock M, Ross E, Lai-Kuen R, Averlant G, Gao Z, Abraham, SN: Phagocytic and tumor necrosis factor alpha response of human mast cells following exposure to gram-negative and gram-positive bacteria. Infect Immun 1998;66:6030-6034.
40. Mielcarek N, Hornquist EH, Johansson BR, Locht C, Abraham SN, Holmgren J: Interaction of Bordetella pertussis with mast cells, modulation of cytokine secretion by pertussis toxin. Cell Microbiol 2001;3: 181-188.
41. Munoz S, Hernandez-Pando R, Abraham SN, Enciso JA: Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J Immunol 2003;170:5590-5596.
42. Tani K, Ogushi F, Kido H, et al: Chymase is a potent chemoattractant for human monocytes and neutrophils. J Leukoc Biol 2000;67:585-589.
43. Malaviya R, Abraham SN: Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J Leukoc Biol 2000;67:841-846.
44. Di Nardo A, Vitiello A, Gallo RL: Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol 2003; 170:2274-2278.
45. Echtenacher B, Mannel DN, Hultner L: Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996;381:75-77.
46. Klimpel GR, Langley KE, Wypych J, Abrams JS, Chopra AK, Niesel DW: A role for stem cell factor (SCF): c-kit interaction(s) in the intestinal tract response to Salmonella typhimurium infection. J Exp Med 1996;184:271-276.
47. Malaviya R, Ikeda T, Ross E, Abraham SN: Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996;381:77-80.
48. Chatterjea D, Burns-Guydish SM, Sciuto TE, Dvorak A, Contag CH, Galli SJ: Adoptive transfer of mast cells does not enhance the impaired survival of Kit(W)/Kit(W-v) mice in a model of low dose intraperitoneal infection with bioluminescent Salmonella typhimurium. Immunol Lett 2005;99:122-129.
49. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376.
50. Naseem KM: The role of nitric oxide in cardiovascular diseases. Mol Aspects Med 2005;26:33-65.
51. Duncan AJ, Heales, SJ: Nitric oxide and neurological disorders. Mol Aspects Med 2005;26:67-96.
52. Kashiwagi S, Kajimura M, Yoshimura Y, Suematsu M: Nonendothelial source of nitric oxide in arterioles but not in venules: alternative source revealed in vivo by diaminofluorescein microfluorography. Circ Res 2002; 91:e55-e64.
53. Bacci S, Arbi-Riccardi R, Mayer B, Rumio C, Borghi-Cirri MB: Localization of nitric oxide synthase immunoreactivity in mast cells of human nasal mucosa. Histochemistry 1994;102:89-92.
54. Bacci S, Rucci L, Riccardi-Arbi R, Borghi-Cirri MB: Colocalization of tumor necrosis factor-alpha and nitric oxide-synthase immunoreactivity in mast cell granules of nasal mucosa. Histol Histopathol 1998;13:1011-1014.
55. Gilchrist M: Control mechanisms of mast cell derived nitric oxide, PhD thesis, University of Alberta, Edmonton, Canada, 2004.
56. Wills FL, Gilchrist M, Befus AD: Interferon-gamma regulates the interaction of RBL-2H3 cells with fibronectin through production of nitric oxide. Immunology 1999;97:481-489.
57. Gajkowska B, Gniadecki R: Induction of endothelial nitric oxide synthase in perivascular mast cells in rat neurohypophysis after ischemia. Neuroendocrinol Lett 1999;20:189-193.
58. Gajkowska B, Viron A, Cholewinski M: Immunocytochemical localization of endothelial nitric oxide synthase (e-NOS) and inducible nitric oxide synthase (i-NOS) in rat neurohypophysis after transient cerebral ischemia. Folia Neuropathol 1999;37:10-19.
59. Huang J, Roby KF, Pace JL, Russell SW, Hunt JS: Cellular localization and hormonal regulation of inducible nitric oxide synthase in cycling mouse uterus. J Leukoc Biol 1995;57:27-35.
60. Hunt JS, Miller L, Vassmer D, Croy BA: Expression of the inducible nitric oxide synthase gene in mouse uterine leukocytes and potential relationships with uterine function during pregnancy. Biol Reprod 1997;57: 827-836.
61. Barker JE, Knight KR, Romeo R, Hurley JV, Morrison WA, Stewart AG: Targeted disruption of the nitric oxide synthase 2 gene protects against ischaemia/reperfusion injury to skeletal muscle. J Pathol 2001;194:109-115.
62. Kane AJ, Barker JE, Mitchel, GM, et al: Inducible nitric oxide synthase (iNOS) activity promotes ischaemic skin flap survival. Br J Pharmacol 2001;132:1631-1638.
63. Messina A, Knight KR, Dowsing BJ, et al: Localization of inducible nitric oxide synthase to mast cells during ischemia/reperfusion injury of skeletal muscle. Lab Invest 2000;80:423-431.
64. Koda W, Harada K, Tsuneyama K, et al: Evidence of the participation of peribiliary mast cells in regulation of the peribiliary vascular plexus along the intrahepatic biliary tree. Lab Invest 2000;80:1007-1017.
65. Bidri M, Ktorza S, Vouldoukis I, et al: Nitric oxide pathway is induced by Fc epsilon RI and up-regulated by stem cell factor in mouse mast cells. Eur J Immunol 1997;27:2907-2913.
66. Hogaboam CM, Befus AD, Wallace JL: Modulation of rat mast cell reactivity by IL-1 beta. Divergent effects on nitric oxide and platelet-activating factor release. J Immunol 1993;151:3767-3774.
67. Kim SJ, Jeong HJ, Choi IY, et al: Cyclooxygenase-2 inhibitor SC-236 [4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1-pyrazol-1-1] benzenesulfonamide] suppresses nuclear factor-kappaB activation and phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and c-Jun N-terminal kinase in human mast cell line cells. J Pharmacol Exp Ther 2005;314:27-34.
68. Shimizu Y, Sakai M, Umemura Y, Ueda H: Immunohistochemical localization of nitric oxide synthase in normal human skin: expression of endothelial-type and inducible-type nitric oxide synthase in keratinocytes. J Dermatol 1997;24:80-87.
69. Kitajima I, Kawahara K, Nakajima T, Soejima Y, Matsuyama T, Maruyama I: Nitric oxide-mediated apoptosis in murine mastocytoma. Biochem Biophys Res Commun 1994;204:244-251.
70. Bissonnette EY, Hogaboam CM, Wallace JL, Befus AD: Potentiation of tumor necrosis factor-alpha-mediated cytotoxicity of mast cells by their production of nitric oxide. J Immunol 1991;147:3060-3065.
71. Lin TJ, Befus AD: Differential regulation of mast cell function by IL-10 and stem cell factor. J Immunol 1997;159:4015-4023.
72. Deschoolmeester ML, Eastmond NC, Dearman RJ, Kimber I, Basketter DA, Coleman JW: Reciprocal effects of interleukin-4 and interferon-gamma on immunoglobulin E-mediated mast cell degranulation: a role for nitric oxide but not peroxynitrite or cyclic guanosine monophosphate. Immunology 1999;96:138-144.
73. Gilchrist M, Hesslinger C, Befus AD: Tetrahydrobiopterin, a critical factor in the production and role of nitric oxide in mast cells. J Biol Chem 2003;278: 50607-50614.
74. Masini E, Salvemini D, Pistelli A, Mannaioni PF, Vane JR: Rat mast cells synthesize a nitric oxide like-factor which modulates the release of histamine. Agents Actions 1991;33:61-63.
75. Mannaioni PF, Masini E, Pistelli A, Salvemini D, Vane, JR: Mast cells as a source of superoxide anions and nitric oxide-like factor: relevance to histamine release. Int J Tissue React 1991;13:271-278.
76. Iikura M, Takaishi T, Hirai K, et al: Exogenous nitric oxide regulates the degranulation of human basophils and rat peritoneal mast cells. Int Arch Allergy Immunol 1998;115:129-136.
77. Bidri M, Becherel PA, Le Goff L, et al: Involvement of cyclic nucleotides in the immunomodulatory effects of nitric oxide on murine mast cells. Biochem Biophys Res Commun 1995;210:507-517.
78. Kanwar S, Wallace JL, Befus D, Kubes P: Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am J Physiol 1994;266:G222-G229.
79. Coffey MJ, Phare S. M, Peters-Golden M: Interaction between nitric oxide, reactive oxygen intermediates, and peroxynitrite in the regulation of 5-lipoxygenase metabolism. Biochim Biophys Acta 2002;1584:81-90.
80. Mollace V, Muscoli C, Masini E, Cuzzocrea S, Salvemini D: Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 2005;57:217-252.
81. Eastmond NC, Banks EM., Coleman JW: Nitric oxide inhibits IgE-mediated degranulation of mast cells and is the principal intermediate in IFN-gamma-induced suppression of exocytosis. J Immunol 1997;159: 1444-1450.
82. Munoz S, Marcet-Palacios M, Befus AD: Production of nitric oxide by mast cells from different rat strains. Abstract - Allergy, Asthma Clin Immunol 2005;1:112.
83. Ischiropoulos H, Gow A: Pathophysiological functions of nitric oxide-mediated protein modifications. Toxicology 2005;208:299-303.
84. Gow AJ, Farkouh CR, Munson DA, Posencheg MA, Ischiropoulos H: Biological significance of nitric oxide-mediated protein modifications. Am J Physiol Lung Cell Mol Physiol 2004;287:L262-L268.
85. MacMillan-Crow LA, Crow JP, Thompson JA: Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 1998;37: 1613-1622.
86. Yamakura F, Taka H, Fujimura T, Murayama K: Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem 1998;273: 14085-14089.
87. Cassina AM, Hodara R, Souza JM, et al: Cytochrome c nitration by peroxynitrite. J Biol Chem 2000;275: 21409-21415.
88. Vadseth C, Souza JM, Thomson L, et al: Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species. J Biol Chem 2004;279:8820-8826.
89. Brennan ML, Wu W, Fu X, et al: A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem 2002;277:17415- 17427.
90. Aslan M, Ryan TM, Townes TM, et al: Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization. J Biol Chem 2003;278:4194-4204.
91. Tedeschi G, Cappelletti G, Negri A, et al: Characterization of nitroproteome in neuron-like PC12 cells differentiated with nerve growth factor: identification of two nitration sites in alpha-tubulin. Proteomics 2005;5:2422-2432.
92. Greenacre SA, Ischiropoulos H: Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic Res 2001;34:541-581.
93. Irie Y, Saeki M, Kamisaki Y, Martin E, Murad F: Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immunoreactivity in proteins. Proc Natl Acad Sci USA 2003;100:5634-5639.
94. Radi R: Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci USA 2004;101:4003-4008.
95. Zhan X, Desiderio DM: The human pituitary nitroproteome: detection of nitrotyrosyl-proteins with two-dimensional Western blotting, and amino acid sequence determination with mass spectrometry. Biochem Biophys Res Commun 2004;325:1180-1186.
96. Kanski J, Hong SJ, Schoneich C: Proteomic analysis of protein nitration in aging skeletal muscle and identification of nitrotyrosine-containing sequences in vivo by nanoelectrospray ionization tandem mass spectrometry. J Biol Chem 2005;280:24261-24266.
97. MacMillan-Crow LA, Cruthirds DL: Invited review: manganese superoxide dismutase in disease. Free Radic Res 2001;34:325-336.
98. Kanski J, Behring A, Pelling J, Schoneich C: Proteomic identification of 3-nitrotyrosine-containing rat cardiac proteins: effects of biological aging. Am J Physiol Heart Circ Physiol 2005;288:H371-H381.
99. Balafanova Z, Bolli R, Zhang J, et al: Nitric oxide (NO) induces nitration of protein kinase Cepsilon (PKCepsilon), facilitating PKCepsilon translocation via enhanced PKCepsilon-RACK2 interactions: a novel mechanism of NO-triggered activation of PKCepsilon. J Biol Chem 2002;277:15021-15027.
100. Park SW, Huq MD, Hu X, Wei LN: Tyrosine nitration on p65: a novel mechanism to rapidly inactivate nuclear factor-kappaB. Mol Cell Proteomics 2005;4: 300-309.
101. Sekar Y, Befus AD: Nitration - a possible mechanism in post-translational control of mast cell phenotype and function. Abstract-Allergy, Asthma Clin Immunol 2005;1:115.
102. Stamler JS, Lamas S, Fang FC: Nitrosylation. the prototypic redox-based signaling mechanism. Cell 2001;106:675-683.
103. Stamler JS, Simon DI, Osborne JA, et al: S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 1992;89:444-448.
104. Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS: Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 2005;6:150-166.
105. Benhar M, Stamler JS: A central role for S-nitrosylation in apoptosis. Nat Cell Biol 2005;7:645-646.
106. Forsythe P, Befus AD: Inhibition of calpain is a component of nitric oxide-induced down-regulation of human mast cell adhesion. J Immunol 2003;170:287-293.